Hangzhou AGS Medtech (688581.SH) plans to repurchase company shares for an amount between RMB 35 million and RMB 70 million.
AGS Medtech (688581.SH) announced that the company plans to use the excess funds raised from its initial public offering of RMB ordinary shares to repurchase shares through centralized bidding transactions. The repurchased shares will be fully used for employee stock ownership plans or equity incentives at an appropriate time in the future. The repurchase amount shall not be less than RMB 35 million (inclusive) and not more than RMB 70 million (inclusive). The repurchase price shall not exceed RMB 82.60 per share (inclusive).
Hangzhou AGS Medtech (688581.SH) announced that the company plans to use the excess funds raised from its initial public offering of RMB ordinary shares to repurchase shares through centralized bidding transactions. The repurchased shares will be fully used for employee stock ownership plans or equity incentives at an appropriate time in the future. The repurchase amount shall be no less than RMB 35 million (inclusive) and no more than RMB 70 million (inclusive). The repurchase price shall not exceed RMB 82.60 per share (inclusive).
Related Articles
BILLION IND (02299) repurchased 90,000 shares for HK$500,900 on October 9.
PRU(02378): First interim dividend for 2026 of 8.88 US cents per ordinary share
TIMES CHINA (01233) issued a total of 113,900 shares upon conversion of convertible bonds.
BILLION IND (02299) repurchased 90,000 shares for HK$500,900 on October 9.
PRU(02378): First interim dividend for 2026 of 8.88 US cents per ordinary share
TIMES CHINA (01233) issued a total of 113,900 shares upon conversion of convertible bonds.
